T4.sandy	KeyEntity 1011 1027	gonadal fat mass
T6.sandy	KeyEntity 1127 1141	sex-dependence
T9.sandy	KeyEntity 1288 1304	gonadal fat mass
T10.sandy	Entity 1344 1370	female-biased heritability
T1.sandy	Entity 269 275	gender
T5.sandy	KeyEntity 1050 1073	sex-specific regulation
T8.sandy	Entity 1182 1197	gene expression
T13.sandy	Entity 0 7;20 28	Genetic Analysis
T15.sandy	KeyEntity 34 48	Fat Mass Trait
T16.sandy	Entity 54 73	Complex Inheritance
T17.sandy	KeyEntity 89 104	Sex Specificity
T1.kevin	Entity 161 177	linkage analysis
T2.kevin	Entity 354 381	genetical genomic” analyses
T3.kevin	Entity 509 522	F2 intercross
T4.kevin	Entity 561 569	C57BL/6J
T5.kevin	Entity 574 581	C3H/HeJ
T6.kevin	KeyEntity 588 630	apolipoprotein E null (ApoE−/−) background
T7.kevin	KeyEntity 637 659	BXH.ApoE−/− population
T8.kevin	Entity 682 713	“metabolic syndrome” phenotypes
T9.kevin	Entity 864 909	liver gene expression quantitative trait loci
R2.sandy	participates_in Arg1:T4.sandy Arg2:T5.sandy	
R3.sandy	regulates Arg1:T8.sandy Arg2:T6.sandy	
R4.sandy	participates_in Arg1:T9.sandy Arg2:T10.sandy	
R5.sandy	participates_in Arg1:T15.sandy Arg2:T17.sandy	
R1.kevin	participates_in Arg1:T4.kevin Arg2:T3.kevin	
R2.kevin	participates_in Arg1:T5.kevin Arg2:T3.kevin	
T1	Entity 12 28	Genomic Analysis
T2	Entity 1162 1178	trans regulation
T3	Entity 1154 1157;1168 1178	cis regulation
